Arbor Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Arbor Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-279	Closed	-$22K	–	96
2015 Q4	$22K	Buy	+279	New	+$30.3K	0.02%	119

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Arbor Wealth Management's IBB Position: Q1 2016 in Review

Arbor Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q1 2016, closing a stake of 279 shares — an estimated $22K sold.

Arbor Wealth Management first reported a position in IBB in Q4 2015 and held it in 1 quarter. The position peaked at $22K in Q4 2015. 414 funds tracked by Wall St. Rank hold IBB as of Q1 2016.

Arbor Wealth Management reported no remaining iShares Biotechnology ETF position as of Q1 2016 after selling out during the quarter.
Arbor Wealth Management sold 279 iShares Biotechnology ETF shares in Q1 2016, an estimated $22K.
Arbor Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 1 quarter.
Arbor Wealth Management's iShares Biotechnology ETF position peaked at $22K in Q4 2015.
414 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2016.

Based on Arbor Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.